NCT01801540

Brief Summary

The purpose of this study is to investigate the effect of a meal containing different doses of L-arabinose, on the intestinal sucrase activity after intake We measure this by measuring the glucose, insulin and c-peptide after meals. Other measurements are made (glucagon and GLP-1) to explain the correlations.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2010

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2013

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 28, 2013

Completed
Last Updated

February 28, 2013

Status Verified

February 1, 2013

Enrollment Period

3 months

First QC Date

February 27, 2013

Last Update Submit

February 27, 2013

Conditions

Outcome Measures

Primary Outcomes (3)

  • Glucose

    Level of glucose over time, The AUC, the peak value and time to peak

    -15, 0, 15, 30, 45, 60, 90, 120, 180 min

  • Insulin

    Level of insulin over time, the AUC, the peak value and time to peak

    -15, 0, 15, 30, 45, 60, 90, 120, 180 min

  • C-peptide

    Level of c-peptide over time, The AUC, the peak value and time to peak

    -15, 0, 15, 30, 45, 60, 90, 120, 180 min

Secondary Outcomes (2)

  • Glucagon

    -15, 0, 15, 30, 45, 60, 90, 120, 180 min

  • GLP-1

    -15, 0, 15, 30, 45, 60, 90, 120, 180 min

Study Arms (6)

0% arabinose meal sucrose/starch

EXPERIMENTAL

A meal containing a bon with butter and marmalade, a cup cake, The and water

Dietary Supplement: L-arabinose - effect on glucose metabolism

5 % arabinose meal sucrose/starch

OTHER

A meal containing a bon with butter and marmalade, a cup cake, The and water

Dietary Supplement: L-arabinose - effect on glucose metabolism

10 % arabinose meal sucrose/starch

OTHER

A meal containing a bon with butter and marmalade, a cup cake, The and water

Dietary Supplement: L-arabinose - effect on glucose metabolism

0 % arabinose meal Starch

OTHER

A meal containing two bons with butter and cheese, The and water

Dietary Supplement: L-arabinose - effect on glucose metabolism

5 % arabinose meal starch

OTHER

A meal containing two bons with butter and cheese, The and water

Dietary Supplement: L-arabinose - effect on glucose metabolism

10 % arabinose meal starch

OTHER

A meal containing two bons with butter and cheese, The and water

Dietary Supplement: L-arabinose - effect on glucose metabolism

Interventions

L-arabinose is mixed into the dough of the buns and cup cakes

0 % arabinose meal Starch0% arabinose meal sucrose/starch10 % arabinose meal starch10 % arabinose meal sucrose/starch5 % arabinose meal starch5 % arabinose meal sucrose/starch

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male
  • normal weight (BMI 18,5-25 kg/m2)
  • years of age

You may not qualify if:

  • Not healthy,including those with diabetes Mellitus, high bloodpressure, dyslipidemia or a infectious diseases (hepatitis or HIV), gastrointestinal disorders
  • Central adipositas (defined as waist circumference \> 94 cm for european men)
  • Daily intake of vitamins and minerals, 3 months before the trail starts and during the trail.
  • elevated alcoholcunsumption(\> 21 units af alcohol pr. week)
  • take medicine
  • Elite athlete with intensive training
  • given bloddonation within the last 3 months
  • smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Jens Rikardt Andersen, MD, lector

    Unit of Nutrition 5711, Rigshospitalet, Blegdamsvej 9, 2100 København Ø

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.Med.Sci./Ph.D.

Study Record Dates

First Submitted

February 27, 2013

First Posted

February 28, 2013

Study Start

December 1, 2010

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

February 28, 2013

Record last verified: 2013-02